Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
October 23rd, 2014
Wogan and Goldman Represent Hasbro in Trial Over Dungeons & Dragons Film Rights
Frankfurt Kurnit's Maura Wogan and Jeremy Goldman represent Hasbro and Wizards of the Coast in a dispute focusing on questions at the heart of the entertainment business: What is a "sequel," what is a "television movie," and when do motion picture rights – once licensed – revert to their original owner? The dispute between our clients and defendant Sweetpea Entertainment centers on who owns the motion picture rights to Dungeons & Dragons – a role-playing game that both Universal Pictures and Warner Bros. want to turn into a new movie franchise. We just completed a 6-day trial in federal court in Los Angeles and are awaiting a decision.
You can find Hollywood Reporter coverage here and here, Deadline coverage here and here, and Courthouse News coverage here, here, here, here, and here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
